Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

NASDAQLPCN
FormDescriptionDateFormat
10-QQuarterly report which provides a continuing view of a company's financial positionAug 7, 2019View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
10-Q/AAmendment to a previously filed 10-QMay 15, 2019View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionMay 8, 2019View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
10-QQuarterly report which provides a continuing view of a company's financial positionNov 7, 2018View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL